Lentiviral-mediated gene silencing of Notch-4 inhibits in vitro proliferation and perineural invasion of ACC-M cells

  • Authors:
    • Wei Chen
    • Huali Zhang
    • Jiandong Wang
    • Gang Cao
    • Zhen Dong
    • Han Su
    • Xiaojun Zhou
    • Senlin Zhang
  • View Affiliations

  • Published online on: February 28, 2013     https://doi.org/10.3892/or.2013.2317
  • Pages: 1797-1804
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Salivary adenoid cystic carcinoma (SACC) is a common type of salivary gland cancer. The poor long-term prognosis for patients with SACC is mainly due to local recurrence, perineural invasion (PNI) and distant metastasis. Notch signaling plays a critical role in determining cell fate such as proliferation, differentiation and apoptosis. Accumulating evidence indicates that aberrant Notch-4 expression has a tumor-promoting function in SACC. In the present study, we used lentiviral-mediated RNA interference (RNAi) targeted against Notch-4 to determine the effects of decreased levels of this protein in the human highly metastatic adenoid cystic carcinoma cell line ACC-M. Furthermore, the proliferative capability as well as the PNI potential of the treated cells were observed in vitro. Our studies demonstrated that RNAi directed against Notch-4 markedly decreased Notch-4 gene expression, resulting in the inhibition of cell proliferation, and G0/G1 to S phase arrest in ACC-M cells. Knockdown of Notch-4 also resulted in a decrease in the in vitro PNI activity in ACC-M cells. To conclude, RNAi targeting against Notch-4 induces the suppression of cell growth and inhibition of PNI in vitro in ACC-M cells. Notch-4 may play an important role in regulating proliferation and PNI activity of SACC.

Introduction

Salivary adenoid cystic carcinoma (SACC) is a common type of salivary gland malignancy, and accounts for 25% of malignant tumors in the major salivary glands (1) and 50% in the minor glands (2). The neoplasm is characterized by heterogeneous phenotypic features and persistently progressive biological behavior. The poor long-term prognosis for patients with adenoid cystic carcinoma is mainly due to local recurrence related to perineural invasion (PNI) and delayed onset of distant metastasis, particularly to the lungs (3,4). PNI, a frequent occurrence in SACC, is difficult to be identified clinically and this often prevents complete surgical resection (5). Vrielinck et al(6) reported the relationship between PNI and poor prognosis. PNI has also been observed frequently in other types of cancer such as melanoma, prostate and pancreatic carcinomas as well as head and neck cancers and is recognized as one of the most important prognostic factors (711). Due to their predilection for nerves, these cancers are known as ‘neurotropic cancers’.

Notch signaling is a pathway highly conserved through evolution which regulates various physiological processes, including stem cell maintenance, differentiation, proliferation and apoptosis (12,13). In mammals, key components of the Notch pathway include four transmembrane receptors (Notch-1, Notch-2, Notch-3 and Notch-4) and five ligands (Dll1, Dll3, Dll4 and Jagged-1, -2) (14,15). Direct binding of a ligand from a signaling cell to a Notch receptor on the membrane of the receiving cell initiates two successive proteolytic cleavages by TACE (TNF-α-converting enzyme) and the γ-secretase/presenilin complex, which ultimately results in the release of the intracellular domain (N-IC). N-IC then translocates into the nucleus and directly interacts with the DNA binding protein CBF-1/Su(H)/Lag-1 (CSF) that activates the transcription of target genes including the hairy/enhancer-of-split (HES-1) (16).

Accumulating evidence strongly indicates that aberrant Notch signaling has a tumor-promoting function in many types of tumors, and Notch signaling may be a promising target for cancer treatment. A role for Notch signaling in salivary gland adenocarcinoma cells has been suggested which proposes that 5′-nitro-indirubinoxime (5′-NIO) induces G0/G1 cell cycle arrest and apoptosis by the downregulation of Notch-1 signaling (17). Notch-1 cross-talk has also been reported in other major cell growth and apoptotic regulatory pathways through modulating the activity of the transcription factor, for example, nuclear factor (NF)-κB and Wnt/β-catenin signaling (18,19). Notch signaling may contribute to squamous cell carcinogenesis, and it is considered as a candidate marker for squamous cell carcinomas of the head and neck (HNSCC) (20). It was reported that the Notch signaling pathway also contributes to the drug resistance of cancer cells. Inhibition of Notch signaling was found to prevent drug resistance and enhanced chemosensitivity in human myeloma, breast cancer and HNSCC (2123). In SACC, a recent study suggested that Notch-4 activation contributes to SACC metastasis (24).

In our previous microarray study, Notch-4 was found to play a potential important role in the pathobiology of SACC associated with PNI (25). Thus, we tested our hypothesis on whether knockdown of Notch-4 by short hairpin RNA (shRNA) inhibits the in vitro proliferation and PNI in ACC-M cells.

To examine our hypothesis, we silenced Notch-4 expression in a human highly metastatic SACC cell line, ACC-M (26), by lentiviral vector-mediated RNA interference (RNAi) technology, and evaluated the effect of Notch-4 on cell growth, cell cycle distribution and cell PNI activity in ACC-M cells. Our data showed that Notch-4 RNAi had antiproliferative activity by modulating G0/G1 and S cell cycle regulators. The knockdown of Notch-4 expression by lentiviral vector-mediated RNAi reduced the PNI activity in vitro in SACC cells. These results suggest that Notch-4 plays an important role in regulating the in vitro growth, proliferation and PNI of ACC-M cells. The suppression of Notch-4 may be a potential therapeutic strategy for SACC.

Materials and methods

Cell lines and cell culture condition

ACC-M and 293T cells were kindly provided by the Department of Oral Biology, School of Stomatology, Fourth Military Medical University, China. The two types of cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen Corp. Carlsbad, CA, USA) supplemented with 10% of fetal bovine serum (FBS) (Gibco, Invitrogen), 2.05 mM of L-glutamine, 100 g/ml of penicillin and 100 μg/ml of streptomycin at 37°C in 5% CO2.

Preparation of Notch-4 lentiviral vectors

Lentiviral vector system (pLenOR-THM, pMDLg/pRRE, pRSV-Rev, pMD2.G) was purchased from Innovation Biotechnology Co., Ltd. (Shanghai, China). Referencing siRNA design strategy (27,28), we selected sites of the gene (NM_004557.3) cDNA sequence and determined the specific sequence by BLAST. Four pairs of siRNA and one negative control were designed and synthesized. As shown in Table I, each pair contained a unique 21-nt (shRNA1 and 2) or 19-nt (shRNA3 and 4) double-stranded human Notch-4 sequence that is presented as an inverted complementary repeat and separated by a loop of a 9-nt spacer. DNA oligonucleotides (Table I) targeting Notch-4 were synthesized and inserted into the MIul and CIal site of the linearized lentiviral-shRNA expression vector according to the manufacturer's instructions. They were incorporated into a pLenOR-THM expression plasmid. The successful ligation was confirmed by the restrictive cleavage and sequenced for an additional verification (Fig. 1). The recombinant vectors were named pLenOR-Notch-4-shRNA1, 2, 3 and 4.

Table I

Oligonucleotide sequences of Notch-4-specific shRNAs.

Table I

Oligonucleotide sequences of Notch-4-specific shRNAs.

NameBase sequence
shRNA1-F 5′-CGCGTCCCCGCAGATATGTAAGGACCAGAATTCAAGAGATTCTGGTCCTTACATATCTGCTTTTTGGAAAT-3′
shRNA1-R 5′-CGATTTCCAAAAAGCAGATATGTAAGGACCAGAATCTCTTGAATTCTGGTCCTTACATATCTGCGGGGA-3′
shRNA2-F 5′-CGCGTCCCCCTGCGATAATGCGAGGAAGATTTCAAGAGAATCTTCCTCGCATTATCGCAGTTTTTGGAAAT-3′
shRNA2-R 5′-CGATTTCCAAAAACTGCGATAATGCGAGGAAGATTCTCTTGAAATCTTCCTCGCATTATCGCAGGGGGA-3′
shRNA3-F 5′-CGCGTCCCCAGATATGTAAGGACCAGAATTCAAGAGATTCTGGTCCTTACATATCTTTTTTGGAAAT-3′
shRNA3-R 5′-CGATTTCCAAAAAAGATATGTAAGGACCAGAATCTCTTGAATTCTGGTCCTTACATATCTGGGGA-3′
shRNA4-F 5′-CGCGTCCCCCGATGGACAGAACTGCTCATTCAAGAGATGAGCAGTTCTGTCCATCGTTTTTGGAAAT-3′
shRNA4-R 5′-CGATTTCCAAAAACGATGGACAGAACTGCTCATCTCTTGAATGAGCAGTTCTGTCCATCGGGGGA-3′
NC-F 5′-CGCGTCCCCTTCTCCGAACGTGTCACGTTTCAAGAGAACGTGACACGTTCGGAGAATTTTTGGAAAT-3′
NC-R 5′-CGATTTCCAAAAATTCTCCGAACGTGTCACGTTCTCTTGAACGTGACACGTTCGGAGAAGGGGA-3′

[i] shRNA1-4 indicates the oligonucleotide sequence of Notch-4. NC, negative control. Underlined section indicates the forward and reverse target sequence; bold section is the restriction enzyme cutting site, including 5′-ACGCGT-3′ (MIul) and 5′-ATCGAT-3′ (CIal). shRNA1 and 3 also include the restriction enzyme cutting site of EcoRI (5′-GAATTC-3′, italicized section).

The recombinant vector was then mixed with virus packaging mix, which including pMDLg/pRRE (HIV-1 gag/pol component), pRSV-Rev (a binding site for the Rev protein which facilitates export of the RNA from the nucleus) and pMD2.G (VSV-G component), packed and transfected by Lipofectamine™ 2000 (Invitrogen) into 293T cells. Viral supernatant was harvested 48 h after transfection, filtered through a 0.45-μm cellulose acetate filter and frozen at −70°C. Virus titer was detected by a 96-well plate dilution method and flow cytometry.

Lentiviral transfection and construction of stable silenced cell lines

Approximately 2×105 ACC-M cells/well were plated in 6-well plates. Twenty-four hours later, ACC-M cells were transfected with 1×107 specific or negative control lentiviral vectors (multiplicity of infection of 25) containing 500 μl enhancing transfection solution (Innovation Biotechnology Co., Ltd.) and 8 μg/ml Polybrene® (Sigma, St. Louis, MO, USA). At 24 h post-transfection, the medium was replaced by normal medium containing 10% FBS and antibiotics. After 96 h post-transfection, the transfected cells were observed under a fluorescence microscope (Leica). As the lentiviral vector contains a GFP expression cassette, the cell transfection rate was directly observed, which reached 90%.

Quantitative RT-PCR

Quantitative RT-PCR (qRT-PCR) for Notch-4 transcripts (shRNA1, 2, 3 and 4) in the ACC-M cell lines was performed. ACC-M cells transfected by zero-loaded lentiviral vector and untreated ACC-M cells were taken as the positive and the negative control separately. Total RNA was extracted from 1×106 cells with TRIzol reagent (Invitrogen). Samples of total RNA (1 μg) were reverse-transcribed into cDNA using a kit according to the manufacturer's instructions (Qiagen, Valencia, CA, USA). qRT-PCR was performed with QuantiTect SYBR Green PCR Master Mix (Qiagen) using the Rotor-Gene RG-3000 Real-Time Thermal Cycler (Corbett Research, Sydney, Australia) and Rotor-Gene software version 6.0.

Each reaction mixture contained 10 μl SYBR-Green Master Mix, 0.5 μl of each sense and antisense primer, 0.5 μl cDNA template supplemented with water to a final volume of 20 μl. The specific primers of Notch-4 (forward, 5′-TCAACACT CCTGGCTCCTTCAACT-3′, and reverse, 5′-AGAGGCAC TCATTGTGATCAGCCT-3′) were amplified as follows: 94°C for 3 min and 40 cycles at 94°C for 30 sec, followed by 61.1°C for 30 sec, 72°C for 20 sec, then ended with 72°C for 10 min for elongation. Human 18S gene was amplified as the internal control (forward, 5′-CGGCTACCACATCCAAGGAA-3′ and reverse, 5′-GCTGGAATTACCGCGGCT-3′). Target genes and the 18S gene were amplified in the same reaction. Each sample was performed in triplicate. Comparative quantification was determined using the 2−ΔΔCt method.

Western blot analysis

Cells were washed twice with cold phosphate-buffered saline and lysed on ice in buffer containing protease inhibitors. Equal amounts of protein (20 μg/lane) from the cell lysates were electrophoresed on 10% acrylamide gels. After SDS-PAGE, proteins were transferred to a polyvinylidene difluoride membrane. The membrane was incubated for 2 h in PBS plus 0.1% Tween 20 and 5% non-fat skim milk to block non-specific binding. Subsequently, the membrane was incubated for 2 h with an antibody against Notch-4 (R&D Systems, Minneapolis, MN, USA). After washing, proteins were visualized using an ECL detection kit with the appropriate HRP-conjugated secondary antibody (Amersham Pharmacia Biotech, Piscataway, NJ, USA). The membranes were stripped and probed with monoclonal antibodies for GAPDH for loading control as per standard protocols. The experiment was repeated three times to confirm the results.

Proliferation assay

The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) colorimetric assay was performed to assess the cell proliferation of the transfected cells. Briefly, the cells were plated in 96-well plates at a density of 103 cells/well. Then for 8 days, every 24 h, a batch of cells were stained with 20 μl sterile MTT dye (5 mg/ml; Sigma-Aldrich) at 37°C for 4 h. The culture medium was then removed, and 150 μl of dimethyl sulphoxide (DMSO) was added and thoroughly mixed in for 10 min. Spectrometric absorbance at 490 nm was measured using a microplate reader. Each group consisted of three wells.

Flow cytometric analysis

Different cell cycle phases (G0/G1, S or G2/M phase) are characterized by different DNA contents. Fluorescence dye propidium iodide (PI) binds with DNA strongly at a ratio of 1:1, and hence the DNA contents of cell cycle phases are reflected by varying PI fluorescent intensities. Stable transfected ACC-M cells, 1×106, were harvested by trypsinization and fixed in 70% ice-cold (4°C) ethanol for 2 h. Cell pellets were resuspended in 1 mg/ml RNase solution (Sigma-Aldrich) for 30 min at 37°C and subsequently in 0.1 mg/ml PI solution (Sigma-Aldrich) at 4°C for 1 h in the dark. Cell cycle analysis was performed on a flow cytometer (Beckman Coulter, Inc., Fullerton, CA, USA).

In vitro perineural invasion assay

The inhibitory effect of RNAi on the PNI ability of ACC-M cells in vitro was demonstrated in modified Boyden chambers. Transwell invasion chambers containing polycarbonate filters (8-μm) (Millipore Corp., Billerica, MA, USA) were coated on the upper surface with Matrigel basement membrane (BD Biosciences, San Diego, CA, USA). Cells (1×105) were suspended in DMEM supplemented with 1% fetal bovine serum and added to the upper chamber. The lower chamber contained 600 μl supernatant of 24 h-cultured RSC96 cells (a rat Schwann cell line, purchased from the Cell Bank for Type Culture Collection, Chinese Academy of Sciences) as a chemoattractant to simulate the perineural surrounding environment (29,30). Cells were incubated for 12 h at 37° in 5% CO2 incubator. At the end of the incubation, the cells on the upper surface of the filter were completely removed by wiping with a cotton swab. The filters were then fixed in methanol and stained with hematoxylin and eosin. Cells that had invaded the Matrigel and had reached the lower surface of the filter were counted under a light microscope at a magnification of ×400. We chose five fields of vision and counted the numbers of the invaded cells on the lower surface of the filter. The assay was performed in triplicate.

Statistical analysis

Results are expressed as means ± standard deviation (SD). Statistical analysis was performed using SPSS 17.0 statistical software (SPSS Inc., Chicago, IL, USA). Data were tested for statistical significance using analysis of variance (ANOVA). Normally distributed, continuous variables were compared using one-way ANOVA. When ANOVA produced a significant difference between groups, multiple comparisons of group means were performed using the Bonferroni procedure with a type I error adjustment. All P-values were two-sided, and significance was defined as P<0.05.

Results

Lentiviral vector-mediated RNAi of Notch-4 causes effective and specific downregulation of Notch-4 expression

The knockdown efficiencies of different Notch-4-specific shRNAs in ACC-M cells were first evaluated using qRT-PCR. Relative Notch-4 mRNA levels in individual stable transfectants were normalized against mRNA levels of an internal control gene, human 18S, performed in the same run. As shown in Fig. 2A, cells transfected with pLenOR-Notch-4-shRNA2, 3 and 4 showed a significantly reduced transcription of Notch-4 mRNA when compared with that of the negative control ACC-M cells and the positive control vector ACC-M Mock, respectively (P<0.01), but there was no significant mRNA transcription reduction in cells transfected with pLenOR-Notch-4-shRNA1. The cells transfected with pLenOR-Notch-4-shRNA2 showed the most significant inhibition of Notch-4 mRNA levels.

Figure 2

Confirmation of Notch-4 expression in different clones by qRT-PCR and western blot analysis in ACC-M cells. (A) Notch-4 mRNA levels were determined by qRT-PCR. Relative fold induction for the Notch-4 mRNA (means ± SD) in mock and Notch-4 siRNA-transfected cells is presented relative to the expression in parental ACC-M cells. Cells transfected with pLenOR-Notch-4-shRNA2, 3, 4 showed a significantly reduced transcription of Notch-4 mRNA when compared with that of the negative control ACC-M cells and the positive control vector ACC-M Mock, respectively, while there was no significant reduction in mRNA transcription in cells transfected with pLenOR-Notch-4-shRNA1 (*P<0.01 compared with ACC-M). (B) Western blot analysis for Notch-4 protein expression in the indicated cell lines. GAPDH was used as a loading control. The Notch-4 protein is a ~210 kDa heterodimer. The Notch-4 protein was split by the lysate, so therefore the western blot analysis detected the intracellular and extracellular domain of Notch-4 protein in the cells. Western blot analysis revealed a decreased expression of Notch-4 protein in the ACC-M cells transfected with pLenOR-Notch-4-shRNA1, 2, 4, while cells transduced by pLenOR-Notch-4-shRNA3 showed no notable reduced expression of Notch-4 protein compared with that of the negative control ACC-M cells and the positive control vector ACC-M Mock. These results revealed that the most effective vector was pLenOR-Notch-4-shRNA2. ACC-M, high metastatic potential control used as a negative control; ACC-M Mock, mock transfection control used as the positive control) pLenOR-Notch-4-shRNA1, 2, 3 and 4 represent the four different clones, respectively.

The Notch-4 protein is a heterodimer ~210 kDa, and the Notch-4 protein was split by the lysate, thus our western blot analysis detected the intracellular and extracellular domain of Notch-4 protein in the cells. In addition, western blot analysis (Fig. 2B) showed reduced expression of Notch-4 protein in the ACC-M cells transfected with pLenOR-Notch-4-shRNA1, 2, 4, while cells transduced by pLenOR-Notch-4-shRNA3 showed no notable decreased expression of Notch-4 protein compared with that of the negative control ACC-M cells and the positive control vector ACC-M Mock. The above results demonstrated that the expression of Notch-4 was specifically and effectively downregulated by Notch-4 RNAi, allowing its application for the subsequent experiment. For the sake of convenience, we chose the most effective vector (pLenOR-Notch-4-shRNA2)-transfected cells, positive and negative control groups to study the cell biological behavior.

Gene silencing of Notch-4 reduces cell proliferation in vitro

The proliferative activity of tumor cells is important in the invasion/metastasis of tumors. To examine whether the knockdown of Notch-4 expression has any effect on cell growth, an MTT cell proliferation assay was performed. Under the same cell culture conditions, the proliferative activity of the pLenOR-Notch-4-shRNA2-transfected cells, negative and positive control cells was almost similar for the first 24 h. With time-lapse, the cells with Notch-4 gene silencing grew more slowly when compared with the control cells. Among the three groups, Notch-4 RNAi (pLenOR-Notch-4-shRNA2) cells showed decreased cell proliferation, when compared to the negative control (ACC-M) and mock-transfected (ACC-M Mock) cells, supporting the role of Notch-4 in the cell growth of ACC-M cells (P<0.01) (Fig. 3).

We next used flow cytometry (FCM) to study the effect of Notch-4-specific shRNA on the cell cycle distribution in ACC-M cells. The negative control group (ACC-M) and positive control group (ACC-M Mock) resulted in a cell cycle distribution of ~53 and 46% of the cells in the S and G2/M phases. In the pLenOR-Notch-4-shRNA2 group, the proliferation index value (PrI) of cycling cells (combined total number of cells in the S and G2/M phases) was decreased to ~39%, with a concomitant increase in the number of cells in the G0/G1 phase (Table II) (Fig. 4). Significant decreases in PrI were found in the pLenOR-Notch-4-shRNA2-transfected cells compared with negative and positive control cells (P<0.01). There was no significant difference in PrI between that of the negative and positive control transfectant cells (P>0.05). These findings indicate that knockdown of Notch-4 expression may inhibit proliferation of ACC-M cells by modulating G0/G1 and S cell cycle regulators.

Table II

FCM analysis of the cell cycle of ACC-M cells after Notch-4-specific inhibition.

Table II

FCM analysis of the cell cycle of ACC-M cells after Notch-4-specific inhibition.

Cell group G0/G1 (%)S (%)G2/M (%)Proliferation index (%)
ACC-M (NC)46.7±1.4545.7±0.967.6±0.5053.3±1.45
ACC-M Mock (PC)54.2±2.0640.2±1.275.5±0.8045.8±2.06
pLenOR-Notch-4-shRNA260.8±1.1237.8±1.161.5±0.1039.2±1.12a

a P1,3<0.01, P2,3<0.01, P1,2>0.05. 1, ACC-M (NC); 2, ACC-M Mock (PC); 3, pLenOR-Notch-4-shRNA2.

Gene silencing of Notch-4 inhibits in vitro perineural invasion ability of ACC-M cells

PNI activity of the effective Notch-4-specific shRNA transfectant (pLenOR-Notch-4-shRNA2) was assayed in vitro by modified Boyden chambers. Cells transfected with pLenOR-Notch-4-shRNA2 showed much lower PNI activities compared with the negative and the positive controls (P<0.01). There was no significant difference in in vitro PNI ability between the negative and positive control transfectant cells (P>0.05) (Fig. 5). These data confirm that the knockdown of Notch-4 expression inhibits in vitro PNI activity of ACC-M cells.

Discussion

The gene encoding the Notch receptor was discovered almost 90 years ago, and gained its name because partial loss of Notch function resulted in notches in the wing margins of Drosophila(31). It only became apparent some years later that the Notch signaling pathway has been conserved throughout evolution. The Notch signaling pathway plays a pivotal role in several cell functions, such as cell fate decisions, cell proliferation, differentiation and cell death during development and postnatal life in species as diverse as Drosophila, worms and vertebrates (3236). In the mammalian system, there are four Notch receptors (Notch-1, Notch-2, Notch-3 and Notch-4) and five known ligands (Dll1, Dll3, Dll4 and Jagged-1, -2) (14,15). Notch is a cellular fate determinant and can induce cell proliferation and/or differentiation, depending on the cellular environment (37). A recent study showed that targeting Notch-1 and Notch-4 may provide a new therapeutic strategy for triple-negative and possibly other breast cancer subtypes (38). In SACC, Notch-4 may play a key role in SACC metastasis, and inhibition of Notch-4 gene expression may have potential therapeutic application in treating metastatic patients (24).

Perineural invasion (PNI), is a typical biological behavior of SACC, which may prevent a complete surgical resection (5). PNI is associated with poor prognosis in SACC patients (6). In our previous study, we established the gene expression profile of SACC associated with PNI by combining the use of laser capture microdissection (LCM) and cDNA microarray. In the profile, Notch-4 was notably overexpressed in the PNI cell group, and this was verified by qRT-PCR (25). Thus, we hypothesized that inhibition of Notch-4 gene expression may reduce in vitro proliferation and PNI in ACC-M cells.

To understand the biological function of Notch-4 in SACC, we examined the effects of a decreased expression of Notch-4 in a human highly metastatic SACC cell line, ACC-M, using a lentiviral-mediated RNAi system. RNAi uses the phenomenon by which double-strand RNA induces potent and specific inhibition of eukaryotic gene expression through the degradation of complementary messenger RNA (mRNA) and is functionally similar to the processes of post-transcriptional gene silencing (39). In the past few years, siRNA and shRNA have been widely used to silence the expression of many target genes, and both methods have had great achievement, but the silencing effect lasts for less than 2 weeks. New systems based on lentiviral vectors have provided new solutions to achieving stable shRNA-mediated knockdown (40,41).

In the present study, we used a lentiviral-mediated RNAi method to obtain effective knockdown of the Notch-4 gene in ACC-M cells and constructed stable silencing clones.

Here, we designed four shRNAs targeted at the Notch-4 gene and successfully transfected them into ACC-M cells. Among the four designed shRNAs, the cells transfected with pLenOR-Notch-4-shRNA2 showed the most significant inhibitory effect as determined by qRT-PCR and western blot analysis. The results indicated that lentiviral-mediated RNAi of Notch-4 silenced the expression of Notch-4 effectively and specifically in ACC-M cells.

We next examined the consequence of ACC-M cells transfected with Notch-4-specific shRNA. The proliferation of the ACC-M cells in which the Notch-4 gene was knocked down was inhibited compared with that of the positive or negative control. In the FCM study, the Notch-4-knockdown ACC-M cells showed an arrest in G0/G1-to-S transition, suggesting growth inhibition of these cells (Table II). Therefore, Notch-4 may be a positive regulator of cell growth to promote a mitogenic signal, which then enhances cell proliferation of ACC-M cells.

In the present study, the silencing of Notch-4 in ACC-M cells inhibited the cell PNI activity in vitro. This result was consistent with the results of the MTT assay and FCM analysis which revealed that silencing of Notch-4 by lentiviral-mediated RNAi inhibited the cell proliferation in vitro by modulating G0/G1 and S cell cycle regulators. The finding may also be associated with the metastasic ability of Notch-4 in SACC and breast cancer (24,38).

SACC is a common subtype of salivary gland malignancy, and it has an important biological behavior for PNI. It is urgent to develop new therapeutic strategies for SACC. In this report, the knockdown of Notch-4 expression by lentiviral-mediated RNAi successfully inhibited the malignant behaviors of ACC-M cells, particularly PNI ability in vitro, implicating that Notch-4 may be a new candidate target gene for the treatment of SACC.

Acknowledgements

This study was supported by grants from the National Natural Science Foundation of China (Project no. 81102051), the Natural Science Foundation of Jiangsu Province (Project no. BK2011659) and the Youth Foundation of Nanjing Jinling Hospital (Project no. 2010Q009).

Abbreviations:

SACC

salivary adenoid cystic carcinoma

PNI

perineural invasion

siRNA

small interfering RNA

shRNA

short hairpin RNA

TACE

TNF-α-converting enzyme

NF-κB

nuclear factor-κB

FCM

flow cytometry

References

1 

Renehan A, Gleave EN, Hancock BD, Smith P and McGurk M: Long-term follow-up of over 1000 patients with salivary gland tumours treated in a single centre. Br J Surg. 83:1750–1754. 1996. View Article : Google Scholar : PubMed/NCBI

2 

Anderson JN Jr, Beenken SW, Crowe R, Soong SJ, Peters G, Maddox WA and Urist MM: Prognostic factors in minor salivary gland cancer. Head Neck. 17:480–486. 1995. View Article : Google Scholar : PubMed/NCBI

3 

Van der Wal JE, Becking AG, Snow GB and van der Waal I: Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head Neck. 24:779–783. 2002.PubMed/NCBI

4 

Ramer N, Wu H, Sabo E, Ramer Y, Emanuel P, Orta L and Burstein DE: Prognostic value of quantitative p63 immuno- staining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis. Cancer. 116:77–83. 2010.PubMed/NCBI

5 

Van der Wal JE, Snow GB and van der Waal I: Intraoral adenoid cystic carcinoma. The presence of perineural spread in relation to site, size, local extension, and metastatic spread in 22 cases. Cancer. 66:2031–2033. 1990.PubMed/NCBI

6 

Vrielinck L, Ostyn F, van Damme B, van den Boqaert W and Fossion E: The significance of perineural spread in adenoid cystic carcinoma of the major and minor salivary glands. Int J Oral Maxillofac Surg. 17:190–193. 1988. View Article : Google Scholar : PubMed/NCBI

7 

Newlin HE, Morris CG, Amdur RJ and Mendenhall WM: Neurotropic melanoma of the head and neck with clinical perineural invasion. Am J Clin Oncol. 28:399–402. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Ayala GE, Dai H, Ittmann M, Li R, Powell M, Frolov A, Wheeler TM, Thompson TC and Rowley D: Growth and survival mechanisms associated with perineural invasion in prostate cancer. Cancer Res. 64:6082–6090. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Pour PM, Bell RH and Batra SK: Neural invasion in the staging of pancreatic cancer. Pancreas. 26:322–325. 2003. View Article : Google Scholar : PubMed/NCBI

10 

Faqan JJ, Collins B, Barnes L, D'Amico F, Myers EN and Johnson JT: Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 124:637–640. 1998. View Article : Google Scholar : PubMed/NCBI

11 

Rahima B, Shingaki S, Nagata M and Saito C: Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Radiol Endod. 97:423–431. 2004. View Article : Google Scholar : PubMed/NCBI

12 

Go MJ, Eastman DS and Artavanis-Tsakonas S: Cell proliferation control by Notch signaling in Drosophila development. Development. 125:2031–2040. 1998.PubMed/NCBI

13 

Shelly LL, Fuchs C and Miele L: Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds. J Cell Biochem. 73:164–175. 1999. View Article : Google Scholar : PubMed/NCBI

14 

Bigas A, Martin DI and Milner LA: Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol Cell Biol. 18:2324–2333. 1998.PubMed/NCBI

15 

Mumm JS and Kopan R: Notch signaling: from the outside in. Dev Biol. 228:151–165. 2000. View Article : Google Scholar : PubMed/NCBI

16 

Stockhausen MT, Sjölund J and Axelson H: Regulation of the Notch target gene Hes-1 by TGFalpha induced Ras/MAPK signaling in human neuroblastoma cells. Exp Cell Res. 310:218–228. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Yoon JH, Kim SA, Kwon SM, Park JH, Park HS, Kim YC, Yoon JH and Ahn SG: 5′-Nitro-indirubinoxime induces G1 cell cycle arrest and apoptosis in salivary gland adenocarcinoma cells through the inhibition of Notch-1 signaling. Biochim Biophys Acta. 1800:352–358. 2010.

18 

Yao J, Duan L, Fan M, Yuan J and Wu X: Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: involvement of nuclear factor kappa B inhibition. Int J Gynecol Cancer. 17:502–510. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Duan L, Yao J, Wu X and Fan M: Growth suppression induced by Notch1 activation involves Wnt-β-catenin down-regulation in human tongue carcinoma cells. Biol Cell. 98:479–490. 2006.PubMed/NCBI

20 

Leethanakul C, Patel V, Gillespie J, Pallente M, Ensley JF, Koontongkaew S, Liotta LA, Emmert-Buck M and Gutkind JS: Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene. 19:3220–3224. 2000. View Article : Google Scholar : PubMed/NCBI

21 

Nefedova Y, Sullivan DM, Bolick SC, Dalton WS and Gabrilovich DI: Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood. 111:2220–2229. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Zang S, Chen F, Dai J, Guo D, Tse W, Qu X, Ma D and Ji C: RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer. Oncol Rep. 23:893–899. 2010.PubMed/NCBI

23 

Gu F, Ma Y, Zhang Z, Zhao J, Kobayashi H, Zhang L and Fu L: Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. Oncol Rep. 23:671–676. 2010.PubMed/NCBI

24 

Ding LC, She L, Zheng DL, Huang QL, Wang JF, Zheng FF and Lu YG: Notch-4 contributes to the metastasis of salivary adenoid cystic carcinoma. Oncol Rep. 24:363–368. 2010.PubMed/NCBI

25 

Chen W, Zhang HL, Shao XJ, Jiang YG, Zhao XG, Gao X, Li JH, Yang J, Zhang YF, Liu BL and Sun MY: Gene expression profile of salivary adenoid cystic carcinoma associated with perineural invasion. Tohoku J Exp Med. 212:319–334. 2007. View Article : Google Scholar : PubMed/NCBI

26 

Guan XF, Qiu WL, He RG and Zhou XJ: Selection of adenoid cystic carcinoma cell clone highly metastatic to the lung: an experimental study. Int J Oral Maxillofac Surg. 26:116–119. 1997. View Article : Google Scholar : PubMed/NCBI

27 

Tuschl T: Expanding small RNA interference. Nat Biotechnol. 20:446–448. 2002. View Article : Google Scholar : PubMed/NCBI

28 

Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS and Khvorova A: Rational siRNA design for RNA interference. Nat Biotechnol. 22:326–330. 2004. View Article : Google Scholar : PubMed/NCBI

29 

Wang L, Sun M, Jiang Y, Yang L, Lei D, Lu C, Zhao Y, Zhang P, Yang Y and Li J: Nerve growth factor and tyrosine kinase A in human salivary adenoid cystic carcinoma: expression patterns and effects on in vitro invasive behavior. J Oral Maxillofac Surg. 64:636–641. 2006. View Article : Google Scholar

30 

Chen W, Zhang HL, Jiang YG, Li JH, Liu BL and Sun MY: Inhibition of CD146 gene expression via RNA interference reduces in vitro perineural invasion on ACC-M cell. J Oral Pathol Med. 38:198–205. 2009. View Article : Google Scholar : PubMed/NCBI

31 

Mohr OL: Character changes caused by mutation of an entire region of a chromosome in Drosophila. Genetics. 4:275–282. 1919.PubMed/NCBI

32 

Miele L and Osborne B: Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol. 181:393–409. 1999. View Article : Google Scholar : PubMed/NCBI

33 

Cheng P and Gabrilovich D: Notch signaling in differentiation and function of dendritic cells. Immunol Res. 41:1–14. 2008. View Article : Google Scholar : PubMed/NCBI

34 

Baker NE: Notch signaling in the nervous system. Pieces still missing from the puzzle. Bioessays. 22:264–273. 2000. View Article : Google Scholar : PubMed/NCBI

35 

Artavanis-Tsakonas S, Rand MD and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI

36 

Milner LA and Bigas A: Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. Blood. 93:2431–2448. 1999.PubMed/NCBI

37 

Kopan R and Ilagan MX: The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI

38 

Clementz AG, Rogowski A, Pandya K, Miele L and Osipo C: Notch-1 and Notch-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications. Breast Cancer Res. 13:R632011. View Article : Google Scholar : PubMed/NCBI

39 

Zamore PD, Tuschl T, Sharp PA and Bartel DP: RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell. 101:25–33. 2000. View Article : Google Scholar : PubMed/NCBI

40 

Yamamoto T, Miyoshi H, Yamamoto N, Yamamoto N, Inoue J and Tsunetsugu-Yokota Y: Lentivirus vectors expressing short hairpin RNAs against the U3-overlapping region of HIV nef inhibit HIV replication and infectivity in primary macrophages. Blood. 108:3305–3312. 2006. View Article : Google Scholar : PubMed/NCBI

41 

Desclaux M, Teigell M, Amar L, Vogel R, Gimenez Y, Ribotta M, Privat A and Mallet J: A novel and efficient gene transfer strategy reduces glial reactivity and improves neuronal survival and axonal growth in vitro. PLoS One. 4:e62272009. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

May 2013
Volume 29 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen W, Zhang H, Wang J, Cao G, Dong Z, Su H, Zhou X and Zhang S: Lentiviral-mediated gene silencing of Notch-4 inhibits in vitro proliferation and perineural invasion of ACC-M cells. Oncol Rep 29: 1797-1804, 2013
APA
Chen, W., Zhang, H., Wang, J., Cao, G., Dong, Z., Su, H. ... Zhang, S. (2013). Lentiviral-mediated gene silencing of Notch-4 inhibits in vitro proliferation and perineural invasion of ACC-M cells. Oncology Reports, 29, 1797-1804. https://doi.org/10.3892/or.2013.2317
MLA
Chen, W., Zhang, H., Wang, J., Cao, G., Dong, Z., Su, H., Zhou, X., Zhang, S."Lentiviral-mediated gene silencing of Notch-4 inhibits in vitro proliferation and perineural invasion of ACC-M cells". Oncology Reports 29.5 (2013): 1797-1804.
Chicago
Chen, W., Zhang, H., Wang, J., Cao, G., Dong, Z., Su, H., Zhou, X., Zhang, S."Lentiviral-mediated gene silencing of Notch-4 inhibits in vitro proliferation and perineural invasion of ACC-M cells". Oncology Reports 29, no. 5 (2013): 1797-1804. https://doi.org/10.3892/or.2013.2317